JACC: Case Reports (Nov 2020)

Marked Sinus Bradycardia Associated With Remdesivir in COVID-19

  • James C. Gubitosa, DO,
  • Parul Kakar, MD,
  • Christine Gerula, MD,
  • Hernando Nossa, MD,
  • Diana Finkel, MD,
  • Kristin Wong, MD,
  • Megna Khatri, MD,
  • Hasan Ali, DO

Journal volume & issue
Vol. 2, no. 14
pp. 2260 – 2264

Abstract

Read online

Remdesivir has seen extensive use during the coronavirus disease-2019 pandemic given its clinically proven efficacy against severe acute respiratory syndrome coronavirus type 2. There has been little cited regarding adverse effects. Here we present the case of a patient with marked sinus bradycardia that began acutely on initiation of remdesivir and resolved almost immediately on cessation of the drug. (Level of Difficulty: Beginner.)

Keywords